BlackRock Investment Management, LLC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q1 2016$0
-100.0%
1,4850.0%0.00%
Q4 2015$3,0000.0%1,4850.0%0.00%
Q3 2015$3,0000.0%1,4850.0%0.00%
Q2 2015$3,0000.0%1,485
+122.3%
0.00%
Q1 2015$3,0000.0%6680.0%0.00%
Q4 2014$3,0000.0%6680.0%0.00%
Q3 2014$3,000
-25.0%
6680.0%0.00%
Q2 2014$4,000
-92.3%
668
-91.8%
0.00%
Q1 2014$52,0008,1800.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q4 2014
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$8,593,0004.94%
First Washington CORP 319,250$591,0000.36%
Burt Wealth Advisors 2,625$4,0000.01%
MYCIO WEALTH PARTNERS, LLC 12,000$22,0000.01%
Weiss Multi-Strategy Advisers LLC 31,500$59,0000.00%
Alyeska Investment Group, L.P. 92,225$171,0000.00%
First Eagle Investment Management, LLC 325,559$612,0000.00%
HighTower Advisors, LLC 61,514$114,0000.00%
Cannell & Co. 11,713$22,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 18,553$35,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders